These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 12637750)
1. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Cui H; Cruz-Correa M; Giardiello FM; Hutcheon DF; Kafonek DR; Brandenburg S; Wu Y; He X; Powe NR; Feinberg AP Science; 2003 Mar; 299(5613):1753-5. PubMed ID: 12637750 [TBL] [Abstract][Full Text] [Related]
2. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Cui H; Horon IL; Ohlsson R; Hamilton SR; Feinberg AP Nat Med; 1998 Nov; 4(11):1276-80. PubMed ID: 9809551 [TBL] [Abstract][Full Text] [Related]
3. Loss of imprinting in IGF2 in colorectal carcinoma assessed by microdissection. Maenaka S; Hikichi T; Imai MA; Minamoto T; Kawahara E Oncol Rep; 2006 Apr; 15(4):791-5. PubMed ID: 16525660 [TBL] [Abstract][Full Text] [Related]
5. [The expression and imprinting status of insulin-like growth factor 2 gene in colorectal cancer]. Zhang FR; He XB; Yang YH; Xie W Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):31-4. PubMed ID: 12579496 [TBL] [Abstract][Full Text] [Related]
6. Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer. Zuo QS; Yan R; Feng DX; Zhao R; Chen C; Jiang YM; Cruz-Correa M; Casson AG; Kang XD; Han F; Chen T Mol Carcinog; 2011 May; 50(5):390-6. PubMed ID: 21268128 [TBL] [Abstract][Full Text] [Related]
7. Loss of imprinting of IGF2: a common epigenetic modifier of intestinal tumor risk. Kaneda A; Feinberg AP Cancer Res; 2005 Dec; 65(24):11236-40. PubMed ID: 16357124 [TBL] [Abstract][Full Text] [Related]
8. Loss of imprinting of insulin-like growth factor II is associated with increased risk of proximal colon cancer. Liou JM; Wu MS; Lin JT; Wang HP; Huang SP; Chiu HM; Lee YC; Lin YB; Shun CT; Liang JT Eur J Cancer; 2007 May; 43(8):1276-82. PubMed ID: 17382534 [TBL] [Abstract][Full Text] [Related]
9. Temporal stability and age-related prevalence of loss of imprinting of the insulin-like growth factor-2 gene. Cruz-Correa M; Zhao R; Oviedo M; Bernabe RD; Lacourt M; Cardona A; Lopez-Enriquez R; Wexner S; Cuffari C; Hylind L; Platz E; Cui H; Feinberg AP; Giardiello FM Epigenetics; 2009 Feb; 4(2):114-8. PubMed ID: 19242102 [TBL] [Abstract][Full Text] [Related]
10. Loss of insulin-like growth factor-II imprinting and the presence of screen-detected colorectal adenomas in women. Woodson K; Flood A; Green L; Tangrea JA; Hanson J; Cash B; Schatzkin A; Schoenfeld P J Natl Cancer Inst; 2004 Mar; 96(5):407-10. PubMed ID: 14996863 [TBL] [Abstract][Full Text] [Related]
11. Association of 11q loss, trisomy 12, and possible 16q loss with loss of imprinting of insulin-like growth factor-II in Wilms tumor. Watanabe N; Nakadate H; Haruta M; Sugawara W; Sasaki F; Tsunematsu Y; Kikuta A; Fukuzawa M; Okita H; Hata J; Soejima H; Kaneko Y Genes Chromosomes Cancer; 2006 Jun; 45(6):592-601. PubMed ID: 16518847 [TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-II methylation status in lymphocyte DNA and colon cancer risk in the Northern Sweden Health and Disease cohort. Kaaks R; Stattin P; Villar S; Poetsch AR; Dossus L; Nieters A; Riboli E; Palmqvist R; Hallmans G; Plass C; Friesen MD Cancer Res; 2009 Jul; 69(13):5400-5. PubMed ID: 19549920 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics of colorectal cancers with loss of imprinting of insulin-like growth factor 2. Sasaki J; Konishi F; Kawamura YJ; Kai T; Takata O; Tsukamoto T Int J Cancer; 2006 Jul; 119(1):80-3. PubMed ID: 16432831 [TBL] [Abstract][Full Text] [Related]
14. Imprinting and colorectal cancer. Miyaki M Nat Med; 1998 Nov; 4(11):1236-7. PubMed ID: 9809540 [No Abstract] [Full Text] [Related]
15. [Loss of IGF2 imprinting in colorectal cancer]. Wang Y; Li GW; Wen BG Sheng Li Ke Xue Jin Zhan; 2005 Jan; 36(1):71-3. PubMed ID: 15881352 [No Abstract] [Full Text] [Related]
16. Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition. Cruz-Correa M; Cui H; Giardiello FM; Powe NR; Hylind L; Robinson A; Hutcheon DF; Kafonek DR; Brandenburg S; Wu Y; He X; Feinberg AP Gastroenterology; 2004 Apr; 126(4):964-70. PubMed ID: 15057734 [TBL] [Abstract][Full Text] [Related]
17. [Genomic imprinting of insulin-like growth factor II in prostate cancer and its clinical significance]. Liu ZW; Zhou FJ; Luo YM; Qin ZK; Wang DJ; Luo JH; Han H; Li YH; Wang H Ai Zheng; 2006 Jun; 25(6):765-70. PubMed ID: 16764778 [TBL] [Abstract][Full Text] [Related]
18. Plasma insulin-like growth factor-binding protein-2 levels as diagnostic and prognostic biomarker of colorectal cancer. Liou JM; Shun CT; Liang JT; Chiu HM; Chen MJ; Chen CC; Wang HP; Wu MS; Lin JT J Clin Endocrinol Metab; 2010 Apr; 95(4):1717-25. PubMed ID: 20157191 [TBL] [Abstract][Full Text] [Related]
19. Gene therapy for colorectal cancer by adenovirus-mediated siRNA targeting CD147 based on loss of the IGF2 imprinting system. Pan Y; He B; Chen J; Sun H; Deng Q; Wang F; Ying H; Liu X; Lin K; Peng H; Xie H; Wang S Int J Oncol; 2015 Nov; 47(5):1881-9. PubMed ID: 26397886 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer. Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]